We demonstrated a 2.5-fold increase in retinal GFAP using proteomic analysis, validated by Western blot analysis, in our OIR model of 50–12% IH [48], and confirmed by immunofluorescence [45]. The gene discussed is GFAP; the disease is isolated hemihyperplasia.